Specialty genomic lab testing

Ended Definitive Contract Awarded Last action

Contract number
36C24821C0042
Awardee
Awarding agency
Obligated
$196,685

Award facts

Opportunity
  • 36C24821Q1258 Solicitation number
Contract value 35% obligated
  • $450,860.79 Current, with exercised options
  • $563,751.90 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Bay Pines, FL 33744, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00012 · MOD to add clins- decrease to close -$29,964
Supplemental Agreement for work within scope P00011 · MOD to add clins $0
Supplemental Agreement for work within scope P00010 · OY3 specialty genomic lab testing DE-obligate to close -$13,764
Exercise an Option P00009 · OY4 specialty genomic lab testing $49,364
Supplemental Agreement for work within scope P00008 -$1,364
Exercise an Option P00007 $49,364
Supplemental Agreement for work within scope P00006 -$14,164
Funding Only Action P00005 -$478
Exercise an Option P00004 · OY2 specialty genomic lab testing $49,364
Exercise an Option P00002 · OY1 specialty genomic lab testing $49,364
Change Order P00003 · Increase for specialty genomic lab testing contract $9,600
Original award $49,364
Show all 12

About this award

Veterans Integrated Service Network 8 awarded a $563,751.90 firm fixed-price definitive contract to Veracyte, Inc. for specialty genomic laboratory testing on July 16, 2021, with ultimate completion on July 15, 2026.

Place of performance is Bay Pines, FL. The originating solicitation describes specialty genomic lab testing and pathology laboratory services. No set-aside was used. This is a modification to add CLINs and decrease to close the contract. Veracyte operates as a direct service provider delivering proprietary molecular genomic testing—including the Afirma Genomic Sequencing Classifier for thyroid nodule assessment and specialty reference laboratory services—to VA healthcare networks and other federal healthcare agencies. The company holds multiple single-award indefinite-delivery contracts and positions on the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule.

Quick answers

Who was awarded contract 36C24821C0042?

36C24821C0042 was awarded to Veracyte, Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on July 16, 2021.

How much is contract 36C24821C0042 worth?

The government has obligated $196,685 on 36C24821C0042. Its current value, with exercised options, is $450,861. Its potential value, with all options, is $563,752.

Was contract 36C24821C0042 competed?

The extent of competition for 36C24821C0042 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award